Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2018 Filed Feb 21, 2018 01:23 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 1,029 | $53.90 | $55,463.10 |
DisclosureSEC source: 0001209191-18-011666 · doc4.xml · nonDerivative · entry 6 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,011 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:23 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Exercise / conversionCommon Stock | 2,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011666 · doc4.xml · nonDerivative · entry 5 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:23 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 1,173 | $53.90 | $63,224.70 |
DisclosureSEC source: 0001209191-18-011666 · doc4.xml · nonDerivative · entry 4 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,963 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:23 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Exercise / conversionCommon Stock | 2,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011666 · doc4.xml · nonDerivative · entry 3 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:23 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 7,804 | $53.90 | $420,635.60 |
DisclosureSEC source: 0001209191-18-011666 · doc4.xml · nonDerivative · entry 2 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,770 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:23 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
GrantCommon Stock | 15,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011666 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,574 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2017 for the one-year period beginning on January 1, 2017 and ended December 31, 2017. The maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · derivative · entry 9 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,217 Underlying: Common Stock · 2,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock. F9 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified EBITDA target for the 2017 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year. F8 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · derivative · entry 8 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,296 Underlying: Common Stock · 2,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock. F7 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year. F8 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 1,029 | $53.90 | $55,463.10 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · nonDerivative · entry 6 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,499 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionCommon Stock | 2,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · nonDerivative · entry 5 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 1,173 | $53.90 | $63,224.70 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · nonDerivative · entry 4 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,451 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionCommon Stock | 2,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · nonDerivative · entry 3 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 7,804 | $53.90 | $420,635.60 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · nonDerivative · entry 2 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,258 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:20 UTC |
Scott Brian M.CFO/CAO
|
GrantCommon Stock | 15,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011655 · doc4.xml · nonDerivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,062 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2017 for the one-year period beginning on January 1, 2017 and ended December 31, 2017. The maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:15 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionDeferred Restricted Stock Units · Derivative | 11,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011642 · doc4.xml · derivative · entry 6 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,042 Underlying: Common Stock · 11,377 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock. F7 · derivative.exercise_date: The deferred RSUs identified in this row were granted on December 9, 2015 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified EBITDA target for the 2016 fiscal year, and on the second anniversary of the grant date in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:15 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 9,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011642 · doc4.xml · derivative · entry 5 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,044 Underlying: Common Stock · 9,873 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on December 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization ("EBITDA") target for the 2017 fiscal year, and on the second anniversary of the grant date in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:15 UTC |
SALKA SUSAN RDirector · President and CEO
|
Tax withholdingCommon Stock | 3,885 | $53.90 | $209,401.50 |
DisclosureSEC source: 0001209191-18-011642 · doc4.xml · nonDerivative · entry 4 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,070 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:15 UTC |
SALKA SUSAN RDirector · President and CEO
|
Exercise / conversionCommon Stock | 9,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011642 · doc4.xml · nonDerivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:15 UTC |
SALKA SUSAN RDirector · President and CEO
|
Tax withholdingCommon Stock | 17,343 | $53.90 | $934,787.70 |
DisclosureSEC source: 0001209191-18-011642 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,082 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:15 UTC |
SALKA SUSAN RDirector · President and CEO
|
GrantCommon Stock | 44,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011642 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,425 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2017 for the one-year period beginning on January 1, 2017 and ended December 31, 2017. The maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 22:43 UTC |
Scott Brian M.CFO/CAO
|
SaleCommon Stock | 666 | $55.00 | $36,630.00 |
DisclosureSEC source: 0001209191-18-007116 · doc4.xml · nonDerivative · entry 2 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,321 F3 · shares: The sale of 666 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:43 UTC |
Scott Brian M.CFO/CAO
|
SaleCommon Stock | 5,700 | $55.17 | $314,474.70 |
DisclosureSEC source: 0001209191-18-007116 · doc4.xml · nonDerivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,987 F1 · shares: The sale of 5,700 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in this row represents a weighted average price of $55.171 per share. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
SaleCommon Stock | 8,219 | $55.00 | $452,045.00 |
DisclosureSEC source: 0001209191-18-007101 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,833 F1 · kind: The sale of 8,219 shares of AMN Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 25, 2018 Filed Jan 26, 2018 20:48 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
SaleCommon Stock | 8,219 | $52.00 | $427,388.00 |
DisclosureSEC source: 0001209191-18-005540 · doc4.xml · nonDerivative · entry 1 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,052 F1 · kind: The sale of 8,219 shares of AMN Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 23:20 UTC |
SALKA SUSAN RDirector · President and CEO
|
SaleCommon Stock | 16,819 | $49.60 | $834,257.72 |
DisclosureSEC source: 0001209191-18-003675 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,349 F3 · kind: The sale of 16,819 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in this row represents a weighted average price of $49.6021 per share. These shares were sold in multiple transactions at prices ranging from $49.05 to $49.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 23:20 UTC |
SALKA SUSAN RDirector · President and CEO
|
SaleCommon Stock | 78,400 | $49.30 | $3,865,245.44 |
DisclosureSEC source: 0001209191-18-003675 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,168 F1 · kind: The sale of 78,400 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in this row represents a weighted average price of $49.3016 per share. These shares were sold in multiple transactions at prices ranging from $48.80 to $49.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 09, 2018 Filed Jan 19, 2018 22:13 UTC Amendment |
Jackson Denise LChief Legal Officer
|
SaleCommon Stock | 6,570 | $49.27 | $323,693.39 |
DisclosureSEC source: 0001209191-18-004595 · doc4a.xml · nonDerivative · entry 5 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,542 F4 · kind: The sale of 6,570 shares of AMN Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in this row represents a weighted average price of $49.2684 per share. These shares were sold in multiple transactions at prices ranging from $49.15 to $49.425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F6 · balance_after: The original Form 4 filed on January 9, 2018 is being amended to correct the holdings set forth in Column 5 of Table I to reflect the sale of securities that vested in the original Form 4, but were inadvertently omitted due to an administrative error. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionPerformance Restricted Stock Units · Derivative | 25,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · derivative · entry 9 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,243 Underlying: Common Stock · 25,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The PRSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each PRSU represents a contingent right to receive one share of Common Stock. F11 · derivative.exercise_date: The PRSUs identified in this row were granted on January 5, 2015. If the average closing price of the Company's Common Stock during the first performance period from December 1, 2017 through December 31, 2017 equals or exceeds $26.08 per share, an additional 12,731 PRSUs shall vest and become earned. If the average closing price of the Company's Common Stock during the second performance period from December 1, 2018 through December 31, 2018 equals or exceeds $29.20 per share, an additional 19,243 PRSUs shall vest and become earned. F12 · derivative.expiration_date: PRSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
GrantRestricted Stock Units · Derivative | 7,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · derivative · entry 8 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,113 Underlying: Common Stock · 7,113 shares Expires not disclosed F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F9 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F7 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · derivative · entry 7 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,969 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The RSUs were granted on January 5, 2015 and vest on the third anniversary of the grant date and the grantee's provision of three periods of credited service. F7 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 10,444 | $49.20 | $513,844.80 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · nonDerivative · entry 6 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,687 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
GrantCommon Stock | 25,462 | $49.20 | $1,252,730.40 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · nonDerivative · entry 5 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,131 F4 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a PRSU award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under the first performance period was contingent upon whether the average closing price of the Company's Common Stock from December 1, 2017 through December 31, 2017 equaled or exceeded $26.08 per share. The Compensation Committee performed the calculation for this award on January 5, 2018 and determined that the average closing price of the Company's Common Stock during the first performance period exceeded $26.08 per share. Based on these results, an additional 12,731 PRSUs for this award were deemed earned and vested. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 1,549 | $49.20 | $76,210.80 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · nonDerivative · entry 4 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,669 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
Exercise / conversionCommon Stock | 2,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · nonDerivative · entry 3 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
Tax withholdingCommon Stock | 5,818 | $49.20 | $286,245.60 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · nonDerivative · entry 2 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,249 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:53 UTC |
Scott Brian M.CFO/CAO
|
GrantCommon Stock | 11,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002968 · doc4.xml · nonDerivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,067 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2014 for the 3-year period beginning on January 1, 2015 and ended December 31, 2017 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2018. The Company's Relative TSR measured in the 95th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:51 UTC |
SALKA SUSAN RDirector · President and CEO
|
Tax withholdingCommon Stock | 13,068 | $49.20 | $642,945.60 |
DisclosureSEC source: 0001209191-18-002961 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,568 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:51 UTC |
SALKA SUSAN RDirector · President and CEO
|
GrantCommon Stock | 31,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002961 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,636 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2014 for the 3-year period beginning on January 1, 2015 and ended December 31, 2017 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2018. The Company's Relative TSR measured in the 95th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:44 UTC |
Jackson Denise LChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 3,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002956 · doc4.xml · derivative · entry 6 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,048 Underlying: Common Stock · 3,048 shares Expires not disclosed F7 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F8 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:44 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002956 · doc4.xml · derivative · entry 5 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,256 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2015 and vest on the third anniversary of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:44 UTC |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 847 | $49.20 | $41,672.40 |
DisclosureSEC source: 0001209191-18-002956 · doc4.xml · nonDerivative · entry 4 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,112 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:44 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionCommon Stock | 2,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002956 · doc4.xml · nonDerivative · entry 3 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:44 UTC |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 3,314 | $49.20 | $163,048.80 |
DisclosureSEC source: 0001209191-18-002956 · doc4.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,703 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:44 UTC |
Jackson Denise LChief Legal Officer
|
GrantCommon Stock | 8,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002956 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,017 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2014 for the 3-year period beginning on January 1, 2015 and ended December 31, 2017 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 5, 2018. The Company's Relative TSR measured in the 95th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Exercise / conversionPerformance Restricted Stock Units · Derivative | 25,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · derivative · entry 9 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,243 Underlying: Common Stock · 25,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The PRSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each PRSU represents a contingent right to receive one share of Common Stock. F11 · derivative.exercise_date: The PRSUs identified in this row were granted on January 5, 2015. If the average closing price of the Company's Common Stock during the first performance period from December 1, 2017 through December 31, 2017 equals or exceeds $26.08 per share, an additional 12,731 PRSUs shall vest and become earned. If the average closing price of the Company's Common Stock during the second performance period from December 1, 2018 through December 31, 2018 equals or exceeds $29.20 per share, an additional 19,243 PRSUs shall vest and become earned. F12 · derivative.expiration_date: PRSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
GrantRestricted Stock Units · Derivative | 7,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · derivative · entry 8 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,113 Underlying: Common Stock · 7,113 shares Expires not disclosed F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F9 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F7 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Exercise / conversionRestricted Stock Units · Derivative | 2,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · derivative · entry 7 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,969 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The RSUs were granted on January 5, 2015 and vest on the third anniversary of the grant date and the grantee's provision of three periods of credited service. F7 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 10,444 | $49.20 | $513,844.80 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · nonDerivative · entry 6 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,271 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
GrantCommon Stock | 25,462 | $49.20 | $1,252,730.40 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · nonDerivative · entry 5 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,715 F4 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a PRSU award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under the first performance period was contingent upon whether the average closing price of the Company's Common Stock from December 1, 2017 through December 31, 2017 equaled or exceeded $26.08 per share. The Compensation Committee performed the calculation for this award on January 5, 2018 and determined that the average closing price of the Company's Common Stock during the first performance period exceeded $26.08 per share. Based on these results, an additional 12,731 PRSUs for this award were deemed earned and vested. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:38 UTC |
Henderson RalphPres., Prof. Svc. & Staffing
|
Tax withholdingCommon Stock | 1,549 | $49.20 | $76,210.80 |
DisclosureSEC source: 0001209191-18-002952 · doc4.xml · nonDerivative · entry 4 Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,253 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.